ceftolozane tazobactam
Selected indexed studies
- Ceftolozane and Tazobactam. (, 2006) [PMID:29999828]
- Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study. (Lancet Infect Dis, 2025) [PMID:39701120]
- Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. (Lancet Infect Dis, 2019) [PMID:31563344]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ceftolozane and Tazobactam. (2006) pubmed
- Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study. (2025) pubmed
- Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. (2019) pubmed
- Ceftolozane-tazobactam: When, how and why using it? (2021) pubmed
- Ceftolozane/tazobactam: place in therapy. (2018) pubmed
- Ceftolozane-tazobactam: A new-generation cephalosporin. (2015) pubmed
- Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam. (2024) pubmed
- Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. (2023) pubmed
- Ceftolozane/tazobactam: Literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012-2021). (2024) pubmed
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination. (2015) pubmed